Frequently Asked Questions
The market is segmented based on , By Products and Services (Reagents and Kits, Instruments, Software and Services), Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Rapid Tests, Western Blot Assay, Next-Generation Sequencing and Others), Disease Type (Respiratory Diseases, Diabetes Mellitus, Oncology, Cholesterol, HIV/AIDS, Cold and Flu, Infectious Diseases and Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics and Ambulatory Surgical Centers), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2029
.
The North America Blood Screening Market size was valued at USD 0.00 USD Billion in 2022.
The North America Blood Screening Market is projected to grow at a CAGR of 10.8% during the forecast period of 2023 to 2029.
The major players operating in the market include Enzo Biochem , Meridian Bioscience , BD, Bio-Rad Laboratories , Thermo Fisher Scientific , and others,.
